Global Gabapentin Enacarbil Market Growth 2024-2031

Report ID: 1345398 | Published Date: Jan 2025 | No. of Page: 115 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Gabapentin Enacarbil Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Gabapentin Enacarbil by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Gabapentin Enacarbil by Country/Region, 2017, 2022 & 2028
    2.2 Gabapentin Enacarbil Segment by Type
        2.2.1 Capsule
        2.2.2 Tablet
    2.3 Gabapentin Enacarbil Sales by Type
        2.3.1 Global Gabapentin Enacarbil Sales Market Share by Type (2017-2022)
        2.3.2 Global Gabapentin Enacarbil Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Gabapentin Enacarbil Sale Price by Type (2017-2022)
    2.4 Gabapentin Enacarbil Segment by Application
        2.4.1 Post-Herpetic Neuralgia (PHN)
        2.4.2 Restless Legs Syndrome (RLS)
        2.4.3 Others
    2.5 Gabapentin Enacarbil Sales by Application
        2.5.1 Global Gabapentin Enacarbil Sale Market Share by Application (2017-2022)
        2.5.2 Global Gabapentin Enacarbil Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Gabapentin Enacarbil Sale Price by Application (2017-2022)
3 Global Gabapentin Enacarbil by Company
    3.1 Global Gabapentin Enacarbil Breakdown Data by Company
        3.1.1 Global Gabapentin Enacarbil Annual Sales by Company (2020-2022)
        3.1.2 Global Gabapentin Enacarbil Sales Market Share by Company (2020-2022)
    3.2 Global Gabapentin Enacarbil Annual Revenue by Company (2020-2022)
        3.2.1 Global Gabapentin Enacarbil Revenue by Company (2020-2022)
        3.2.2 Global Gabapentin Enacarbil Revenue Market Share by Company (2020-2022)
    3.3 Global Gabapentin Enacarbil Sale Price by Company
    3.4 Key Manufacturers Gabapentin Enacarbil Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Gabapentin Enacarbil Product Location Distribution
        3.4.2 Players Gabapentin Enacarbil Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Gabapentin Enacarbil by Geographic Region
    4.1 World Historic Gabapentin Enacarbil Market Size by Geographic Region (2017-2022)
        4.1.1 Global Gabapentin Enacarbil Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Gabapentin Enacarbil Annual Revenue by Geographic Region
    4.2 World Historic Gabapentin Enacarbil Market Size by Country/Region (2017-2022)
        4.2.1 Global Gabapentin Enacarbil Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Gabapentin Enacarbil Annual Revenue by Country/Region
    4.3 Americas Gabapentin Enacarbil Sales Growth
    4.4 APAC Gabapentin Enacarbil Sales Growth
    4.5 Europe Gabapentin Enacarbil Sales Growth
    4.6 Middle East & Africa Gabapentin Enacarbil Sales Growth
5 Americas
    5.1 Americas Gabapentin Enacarbil Sales by Country
        5.1.1 Americas Gabapentin Enacarbil Sales by Country (2017-2022)
        5.1.2 Americas Gabapentin Enacarbil Revenue by Country (2017-2022)
    5.2 Americas Gabapentin Enacarbil Sales by Type
    5.3 Americas Gabapentin Enacarbil Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Gabapentin Enacarbil Sales by Region
        6.1.1 APAC Gabapentin Enacarbil Sales by Region (2017-2022)
        6.1.2 APAC Gabapentin Enacarbil Revenue by Region (2017-2022)
    6.2 APAC Gabapentin Enacarbil Sales by Type
    6.3 APAC Gabapentin Enacarbil Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Gabapentin Enacarbil by Country
        7.1.1 Europe Gabapentin Enacarbil Sales by Country (2017-2022)
        7.1.2 Europe Gabapentin Enacarbil Revenue by Country (2017-2022)
    7.2 Europe Gabapentin Enacarbil Sales by Type
    7.3 Europe Gabapentin Enacarbil Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Gabapentin Enacarbil by Country
        8.1.1 Middle East & Africa Gabapentin Enacarbil Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Gabapentin Enacarbil Revenue by Country (2017-2022)
    8.2 Middle East & Africa Gabapentin Enacarbil Sales by Type
    8.3 Middle East & Africa Gabapentin Enacarbil Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Gabapentin Enacarbil
    10.3 Manufacturing Process Analysis of Gabapentin Enacarbil
    10.4 Industry Chain Structure of Gabapentin Enacarbil
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Gabapentin Enacarbil Distributors
    11.3 Gabapentin Enacarbil Customer
12 World Forecast Review for Gabapentin Enacarbil by Geographic Region
    12.1 Global Gabapentin Enacarbil Market Size Forecast by Region
        12.1.1 Global Gabapentin Enacarbil Forecast by Region (2023-2028)
        12.1.2 Global Gabapentin Enacarbil Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Gabapentin Enacarbil Forecast by Type
    12.7 Global Gabapentin Enacarbil Forecast by Application
13 Key Players Analysis
    13.1 Arbor Pharma
        13.1.1 Arbor Pharma Company Information
        13.1.2 Arbor Pharma Gabapentin Enacarbil Product Offered
        13.1.3 Arbor Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Arbor Pharma Main Business Overview
        13.1.5 Arbor Pharma Latest Developments
    13.2 Astellas
        13.2.1 Astellas Company Information
        13.2.2 Astellas Gabapentin Enacarbil Product Offered
        13.2.3 Astellas Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Astellas Main Business Overview
        13.2.5 Astellas Latest Developments
    13.3 GlaxoSmithKline
        13.3.1 GlaxoSmithKline Company Information
        13.3.2 GlaxoSmithKline Gabapentin Enacarbil Product Offered
        13.3.3 GlaxoSmithKline Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 GlaxoSmithKline Main Business Overview
        13.3.5 GlaxoSmithKline Latest Developments
    13.4 Glenmark Pharma
        13.4.1 Glenmark Pharma Company Information
        13.4.2 Glenmark Pharma Gabapentin Enacarbil Product Offered
        13.4.3 Glenmark Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Glenmark Pharma Main Business Overview
        13.4.5 Glenmark Pharma Latest Developments
    13.5 Pfizer
        13.5.1 Pfizer Company Information
        13.5.2 Pfizer Gabapentin Enacarbil Product Offered
        13.5.3 Pfizer Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Pfizer Main Business Overview
        13.5.5 Pfizer Latest Developments
    13.6 Depomed
        13.6.1 Depomed Company Information
        13.6.2 Depomed Gabapentin Enacarbil Product Offered
        13.6.3 Depomed Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Depomed Main Business Overview
        13.6.5 Depomed Latest Developments
    13.7 Teva
        13.7.1 Teva Company Information
        13.7.2 Teva Gabapentin Enacarbil Product Offered
        13.7.3 Teva Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Teva Main Business Overview
        13.7.5 Teva Latest Developments
    13.8 Mylan
        13.8.1 Mylan Company Information
        13.8.2 Mylan Gabapentin Enacarbil Product Offered
        13.8.3 Mylan Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Mylan Main Business Overview
        13.8.5 Mylan Latest Developments
    13.9 Novartis
        13.9.1 Novartis Company Information
        13.9.2 Novartis Gabapentin Enacarbil Product Offered
        13.9.3 Novartis Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Novartis Main Business Overview
        13.9.5 Novartis Latest Developments
    13.10 Apotex
        13.10.1 Apotex Company Information
        13.10.2 Apotex Gabapentin Enacarbil Product Offered
        13.10.3 Apotex Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Apotex Main Business Overview
        13.10.5 Apotex Latest Developments
    13.11 Sun Pharmaceutical
        13.11.1 Sun Pharmaceutical Company Information
        13.11.2 Sun Pharmaceutical Gabapentin Enacarbil Product Offered
        13.11.3 Sun Pharmaceutical Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Sun Pharmaceutical Main Business Overview
        13.11.5 Sun Pharmaceutical Latest Developments
    13.12 Aurobindo Pharma
        13.12.1 Aurobindo Pharma Company Information
        13.12.2 Aurobindo Pharma Gabapentin Enacarbil Product Offered
        13.12.3 Aurobindo Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Aurobindo Pharma Main Business Overview
        13.12.5 Aurobindo Pharma Latest Developments
    13.13 Intas
        13.13.1 Intas Company Information
        13.13.2 Intas Gabapentin Enacarbil Product Offered
        13.13.3 Intas Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Intas Main Business Overview
        13.13.5 Intas Latest Developments
    13.14 Amneal
        13.14.1 Amneal Company Information
        13.14.2 Amneal Gabapentin Enacarbil Product Offered
        13.14.3 Amneal Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.14.4 Amneal Main Business Overview
        13.14.5 Amneal Latest Developments
    13.15 Marksans Pharma
        13.15.1 Marksans Pharma Company Information
        13.15.2 Marksans Pharma Gabapentin Enacarbil Product Offered
        13.15.3 Marksans Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.15.4 Marksans Pharma Main Business Overview
        13.15.5 Marksans Pharma Latest Developments
    13.16 Alkem
        13.16.1 Alkem Company Information
        13.16.2 Alkem Gabapentin Enacarbil Product Offered
        13.16.3 Alkem Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.16.4 Alkem Main Business Overview
        13.16.5 Alkem Latest Developments
    13.17 Jiangsu Enhua
        13.17.1 Jiangsu Enhua Company Information
        13.17.2 Jiangsu Enhua Gabapentin Enacarbil Product Offered
        13.17.3 Jiangsu Enhua Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.17.4 Jiangsu Enhua Main Business Overview
        13.17.5 Jiangsu Enhua Latest Developments
    13.18 Jiangsu Hengrui
        13.18.1 Jiangsu Hengrui Company Information
        13.18.2 Jiangsu Hengrui Gabapentin Enacarbil Product Offered
        13.18.3 Jiangsu Hengrui Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.18.4 Jiangsu Hengrui Main Business Overview
        13.18.5 Jiangsu Hengrui Latest Developments
    13.19 Sailike Pharma
        13.19.1 Sailike Pharma Company Information
        13.19.2 Sailike Pharma Gabapentin Enacarbil Product Offered
        13.19.3 Sailike Pharma Gabapentin Enacarbil Sales, Revenue, Price and Gross Margin (2020-2022)
        13.19.4 Sailike Pharma Main Business Overview
        13.19.5 Sailike Pharma Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Gabapentin Enacarbil Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Gabapentin Enacarbil Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Capsule
    Table 4. Major Players of Tablet
    Table 5. Global Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)
    Table 6. Global Gabapentin Enacarbil Sales Market Share by Type (2017-2022)
    Table 7. Global Gabapentin Enacarbil Revenue by Type (2017-2022) & ($ million)
    Table 8. Global Gabapentin Enacarbil Revenue Market Share by Type (2017-2022)
    Table 9. Global Gabapentin Enacarbil Sale Price by Type (2017-2022) & (US$/Unit)
    Table 10. Global Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)
    Table 11. Global Gabapentin Enacarbil Sales Market Share by Application (2017-2022)
    Table 12. Global Gabapentin Enacarbil Revenue by Application (2017-2022)
    Table 13. Global Gabapentin Enacarbil Revenue Market Share by Application (2017-2022)
    Table 14. Global Gabapentin Enacarbil Sale Price by Application (2017-2022) & (US$/Unit)
    Table 15. Global Gabapentin Enacarbil Sales by Company (2020-2022) & (K Units)
    Table 16. Global Gabapentin Enacarbil Sales Market Share by Company (2020-2022)
    Table 17. Global Gabapentin Enacarbil Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global Gabapentin Enacarbil Revenue Market Share by Company (2020-2022)
    Table 19. Global Gabapentin Enacarbil Sale Price by Company (2020-2022) & (US$/Unit)
    Table 20. Key Manufacturers Gabapentin Enacarbil Producing Area Distribution and Sales Area
    Table 21. Players Gabapentin Enacarbil Products Offered
    Table 22. Gabapentin Enacarbil Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Gabapentin Enacarbil Sales by Geographic Region (2017-2022) & (K Units)
    Table 26. Global Gabapentin Enacarbil Sales Market Share Geographic Region (2017-2022)
    Table 27. Global Gabapentin Enacarbil Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global Gabapentin Enacarbil Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global Gabapentin Enacarbil Sales by Country/Region (2017-2022) & (K Units)
    Table 30. Global Gabapentin Enacarbil Sales Market Share by Country/Region (2017-2022)
    Table 31. Global Gabapentin Enacarbil Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global Gabapentin Enacarbil Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas Gabapentin Enacarbil Sales by Country (2017-2022) & (K Units)
    Table 34. Americas Gabapentin Enacarbil Sales Market Share by Country (2017-2022)
    Table 35. Americas Gabapentin Enacarbil Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas Gabapentin Enacarbil Revenue Market Share by Country (2017-2022)
    Table 37. Americas Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)
    Table 38. Americas Gabapentin Enacarbil Sales Market Share by Type (2017-2022)
    Table 39. Americas Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)
    Table 40. Americas Gabapentin Enacarbil Sales Market Share by Application (2017-2022)
    Table 41. APAC Gabapentin Enacarbil Sales by Region (2017-2022) & (K Units)
    Table 42. APAC Gabapentin Enacarbil Sales Market Share by Region (2017-2022)
    Table 43. APAC Gabapentin Enacarbil Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC Gabapentin Enacarbil Revenue Market Share by Region (2017-2022)
    Table 45. APAC Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)
    Table 46. APAC Gabapentin Enacarbil Sales Market Share by Type (2017-2022)
    Table 47. APAC Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)
    Table 48. APAC Gabapentin Enacarbil Sales Market Share by Application (2017-2022)
    Table 49. Europe Gabapentin Enacarbil Sales by Country (2017-2022) & (K Units)
    Table 50. Europe Gabapentin Enacarbil Sales Market Share by Country (2017-2022)
    Table 51. Europe Gabapentin Enacarbil Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe Gabapentin Enacarbil Revenue Market Share by Country (2017-2022)
    Table 53. Europe Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)
    Table 54. Europe Gabapentin Enacarbil Sales Market Share by Type (2017-2022)
    Table 55. Europe Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)
    Table 56. Europe Gabapentin Enacarbil Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa Gabapentin Enacarbil Sales by Country (2017-2022) & (K Units)
    Table 58. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa Gabapentin Enacarbil Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa Gabapentin Enacarbil Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units)
    Table 62. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units)
    Table 64. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of Gabapentin Enacarbil
    Table 66. Key Market Challenges & Risks of Gabapentin Enacarbil
    Table 67. Key Industry Trends of Gabapentin Enacarbil
    Table 68. Gabapentin Enacarbil Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Gabapentin Enacarbil Distributors List
    Table 71. Gabapentin Enacarbil Customer List
    Table 72. Global Gabapentin Enacarbil Sales Forecast by Region (2023-2028) & (K Units)
    Table 73. Global Gabapentin Enacarbil Sales Market Forecast by Region
    Table 74. Global Gabapentin Enacarbil Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global Gabapentin Enacarbil Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas Gabapentin Enacarbil Sales Forecast by Country (2023-2028) & (K Units)
    Table 77. Americas Gabapentin Enacarbil Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC Gabapentin Enacarbil Sales Forecast by Region (2023-2028) & (K Units)
    Table 79. APAC Gabapentin Enacarbil Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe Gabapentin Enacarbil Sales Forecast by Country (2023-2028) & (K Units)
    Table 81. Europe Gabapentin Enacarbil Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa Gabapentin Enacarbil Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Middle East & Africa Gabapentin Enacarbil Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global Gabapentin Enacarbil Sales Forecast by Type (2023-2028) & (K Units)
    Table 85. Global Gabapentin Enacarbil Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global Gabapentin Enacarbil Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global Gabapentin Enacarbil Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global Gabapentin Enacarbil Sales Forecast by Application (2023-2028) & (K Units)
    Table 89. Global Gabapentin Enacarbil Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global Gabapentin Enacarbil Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global Gabapentin Enacarbil Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Arbor Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 93. Arbor Pharma Gabapentin Enacarbil Product Offered
    Table 94. Arbor Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 95. Arbor Pharma Main Business
    Table 96. Arbor Pharma Latest Developments
    Table 97. Astellas Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 98. Astellas Gabapentin Enacarbil Product Offered
    Table 99. Astellas Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 100. Astellas Main Business
    Table 101. Astellas Latest Developments
    Table 102. GlaxoSmithKline Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 103. GlaxoSmithKline Gabapentin Enacarbil Product Offered
    Table 104. GlaxoSmithKline Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 105. GlaxoSmithKline Main Business
    Table 106. GlaxoSmithKline Latest Developments
    Table 107. Glenmark Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 108. Glenmark Pharma Gabapentin Enacarbil Product Offered
    Table 109. Glenmark Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 110. Glenmark Pharma Main Business
    Table 111. Glenmark Pharma Latest Developments
    Table 112. Pfizer Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 113. Pfizer Gabapentin Enacarbil Product Offered
    Table 114. Pfizer Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 115. Pfizer Main Business
    Table 116. Pfizer Latest Developments
    Table 117. Depomed Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 118. Depomed Gabapentin Enacarbil Product Offered
    Table 119. Depomed Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 120. Depomed Main Business
    Table 121. Depomed Latest Developments
    Table 122. Teva Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 123. Teva Gabapentin Enacarbil Product Offered
    Table 124. Teva Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 125. Teva Main Business
    Table 126. Teva Latest Developments
    Table 127. Mylan Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 128. Mylan Gabapentin Enacarbil Product Offered
    Table 129. Mylan Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 130. Mylan Main Business
    Table 131. Mylan Latest Developments
    Table 132. Novartis Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 133. Novartis Gabapentin Enacarbil Product Offered
    Table 134. Novartis Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 135. Novartis Main Business
    Table 136. Novartis Latest Developments
    Table 137. Apotex Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 138. Apotex Gabapentin Enacarbil Product Offered
    Table 139. Apotex Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 140. Apotex Main Business
    Table 141. Apotex Latest Developments
    Table 142. Sun Pharmaceutical Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 143. Sun Pharmaceutical Gabapentin Enacarbil Product Offered
    Table 144. Sun Pharmaceutical Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 145. Sun Pharmaceutical Main Business
    Table 146. Sun Pharmaceutical Latest Developments
    Table 147. Aurobindo Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 148. Aurobindo Pharma Gabapentin Enacarbil Product Offered
    Table 149. Aurobindo Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 150. Aurobindo Pharma Main Business
    Table 151. Aurobindo Pharma Latest Developments
    Table 152. Intas Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 153. Intas Gabapentin Enacarbil Product Offered
    Table 154. Intas Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 155. Intas Main Business
    Table 156. Intas Latest Developments
    Table 157. Amneal Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 158. Amneal Gabapentin Enacarbil Product Offered
    Table 159. Amneal Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 160. Amneal Main Business
    Table 161. Amneal Latest Developments
    Table 162. Marksans Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 163. Marksans Pharma Gabapentin Enacarbil Product Offered
    Table 164. Marksans Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 165. Marksans Pharma Main Business
    Table 166. Marksans Pharma Latest Developments
    Table 167. Alkem Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 168. Alkem Gabapentin Enacarbil Product Offered
    Table 169. Alkem Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 170. Alkem Main Business
    Table 171. Alkem Latest Developments
    Table 172. Jiangsu Enhua Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 173. Jiangsu Enhua Gabapentin Enacarbil Product Offered
    Table 174. Jiangsu Enhua Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 175. Jiangsu Enhua Main Business
    Table 176. Jiangsu Enhua Latest Developments
    Table 177. Jiangsu Hengrui Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 178. Jiangsu Hengrui Gabapentin Enacarbil Product Offered
    Table 179. Jiangsu Hengrui Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 180. Jiangsu Hengrui Main Business
    Table 181. Jiangsu Hengrui Latest Developments
    Table 182. Sailike Pharma Basic Information, Gabapentin Enacarbil Manufacturing Base, Sales Area and Its Competitors
    Table 183. Sailike Pharma Gabapentin Enacarbil Product Offered
    Table 184. Sailike Pharma Gabapentin Enacarbil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 185. Sailike Pharma Main Business
    Table 186. Sailike Pharma Latest Developments
List of Figures
    Figure 1. Picture of Gabapentin Enacarbil
    Figure 2. Gabapentin Enacarbil Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Gabapentin Enacarbil Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Gabapentin Enacarbil Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Gabapentin Enacarbil Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Capsule
    Figure 10. Product Picture of Tablet
    Figure 11. Global Gabapentin Enacarbil Sales Market Share by Type in 2021
    Figure 12. Global Gabapentin Enacarbil Revenue Market Share by Type (2017-2022)
    Figure 13. Gabapentin Enacarbil Consumed in Post-Herpetic Neuralgia (PHN)
    Figure 14. Global Gabapentin Enacarbil Market: Post-Herpetic Neuralgia (PHN) (2017-2022) & (K Units)
    Figure 15. Gabapentin Enacarbil Consumed in Restless Legs Syndrome (RLS)
    Figure 16. Global Gabapentin Enacarbil Market: Restless Legs Syndrome (RLS) (2017-2022) & (K Units)
    Figure 17. Gabapentin Enacarbil Consumed in Others
    Figure 18. Global Gabapentin Enacarbil Market: Others (2017-2022) & (K Units)
    Figure 19. Global Gabapentin Enacarbil Sales Market Share by Application (2017-2022)
    Figure 20. Global Gabapentin Enacarbil Revenue Market Share by Application in 2021
    Figure 21. Gabapentin Enacarbil Revenue Market by Company in 2021 ($ Million)
    Figure 22. Global Gabapentin Enacarbil Revenue Market Share by Company in 2021
    Figure 23. Global Gabapentin Enacarbil Sales Market Share by Geographic Region (2017-2022)
    Figure 24. Global Gabapentin Enacarbil Revenue Market Share by Geographic Region in 2021
    Figure 25. Global Gabapentin Enacarbil Sales Market Share by Region (2017-2022)
    Figure 26. Global Gabapentin Enacarbil Revenue Market Share by Country/Region in 2021
    Figure 27. Americas Gabapentin Enacarbil Sales 2017-2022 (K Units)
    Figure 28. Americas Gabapentin Enacarbil Revenue 2017-2022 ($ Millions)
    Figure 29. APAC Gabapentin Enacarbil Sales 2017-2022 (K Units)
    Figure 30. APAC Gabapentin Enacarbil Revenue 2017-2022 ($ Millions)
    Figure 31. Europe Gabapentin Enacarbil Sales 2017-2022 (K Units)
    Figure 32. Europe Gabapentin Enacarbil Revenue 2017-2022 ($ Millions)
    Figure 33. Middle East & Africa Gabapentin Enacarbil Sales 2017-2022 (K Units)
    Figure 34. Middle East & Africa Gabapentin Enacarbil Revenue 2017-2022 ($ Millions)
    Figure 35. Americas Gabapentin Enacarbil Sales Market Share by Country in 2021
    Figure 36. Americas Gabapentin Enacarbil Revenue Market Share by Country in 2021
    Figure 37. United States Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Canada Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Mexico Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Brazil Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 41. APAC Gabapentin Enacarbil Sales Market Share by Region in 2021
    Figure 42. APAC Gabapentin Enacarbil Revenue Market Share by Regions in 2021
    Figure 43. China Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Japan Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 45. South Korea Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Southeast Asia Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 47. India Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Australia Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Europe Gabapentin Enacarbil Sales Market Share by Country in 2021
    Figure 50. Europe Gabapentin Enacarbil Revenue Market Share by Country in 2021
    Figure 51. Germany Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 52. France Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 53. UK Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Italy Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Russia Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Country in 2021
    Figure 57. Middle East & Africa Gabapentin Enacarbil Revenue Market Share by Country in 2021
    Figure 58. Egypt Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 59. South Africa Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Israel Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Turkey Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 62. GCC Country Gabapentin Enacarbil Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Manufacturing Cost Structure Analysis of Gabapentin Enacarbil in 2021
    Figure 64. Manufacturing Process Analysis of Gabapentin Enacarbil
    Figure 65. Industry Chain Structure of Gabapentin Enacarbil
    Figure 66. Channels of Distribution
    Figure 67. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Gabapentin Enacarbil Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Gabapentin Enacarbil Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Gabapentin Enacarbil Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports